Core Viewpoint - As of September 18, 2025, the stock price of Kangtong Medical (301515) closed at 21.7 yuan, reflecting a decline of 2.3% with a trading volume of 17,300 hands and a transaction amount of 37.91 million yuan [1] Group 1: Financial Performance - Kangtong Medical reported a main business revenue of 265 million yuan for the first half of 2025, a year-on-year decrease of 39.29% [3] - The net profit attributable to shareholders was -8.4044 million yuan, a year-on-year decline of 154.53% [3] - The second quarter of 2025 saw a single-quarter main business revenue of 241 million yuan, down 33.22% year-on-year [3] - The company’s gross profit margin stood at 22.09%, significantly lower than the industry average of 51.85% [3] Group 2: Market Activity - On September 18, 2025, the net outflow of main funds was 3.1474 million yuan, accounting for 8.3% of the total transaction amount [1][2] - Retail investors experienced a net outflow of 339,900 yuan, representing 0.9% of the total transaction amount [1][2] - Over the past five days, the stock has seen fluctuations in fund flows, with notable net inflows from speculative funds on several days [2] Group 3: Company Metrics and Industry Comparison - Kangtong Medical's total market value is 2.17 billion yuan, significantly lower than the industry average of 12.073 billion yuan [3] - The company has a price-to-earnings ratio of -129.1, indicating negative earnings performance compared to the industry average of 67.82 [3] - The return on equity (ROE) for Kangtong Medical is -0.67%, while the industry average is 1.8% [3]
股票行情快报：港通医疗（301515）9月18日主力资金净卖出314.74万元